Aclaris Therapeutics, Inc.

NEW YORK STATE COMMON RETIREMENT FUND ACRS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

27,300

Value ($000)

82

Weight

0.0%

2019 Q4 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	82	0.0%	27,300	12/31/2025
2025 Q3	11/3/2025	92	0.0%	48,400	9/30/2025
2025 Q2	10/8/2025	91	0.0%	64,200	6/30/2025
2024 Q2	10/8/2025	1	0.0%	586	6/30/2024
2024 Q1	10/8/2025	10	0.0%	7,704	3/31/2024
2023 Q4	10/8/2025	8	0.0%	7,155	12/31/2023
2023 Q3	10/8/2025	185	0.0%	27,043	9/30/2023
2023 Q2	10/8/2025	278	0.0%	26,811	6/30/2023
2023 Q1	10/8/2025	217	0.0%	26,858	3/31/2023
2022 Q4	10/8/2025	736	0.0%	46,739	12/31/2022
2022 Q3	11/8/2022	737	0.0%	46,808	9/30/2022
2022 Q2	8/4/2022	542	0.0%	38,855	6/30/2022
2022 Q1	7/1/2022	672	0.0%	38,955	3/31/2022
2021 Q4	2/2/2022	455	0.0%	31,327	12/31/2021
2021 Q3	11/2/2021	564	0.0%	31,347	9/30/2021
2021 Q2	8/2/2021	653	0.0%	37,200	6/30/2021
2020 Q1	5/6/2020	31	0.0%	29,649	3/31/2020
2019 Q4	2/5/2020	56	0.0%	29,649	12/31/2019